Revised: February 13, 2010
Medhold NV will be acquired for about U.S. $316 million
Sonic Healthcare, Ltd., (SHL.AX) of Sydney, Australia, said last Friday that it would acquire 100% of Medhold NV, a clinical pathology laboratory based in Antwerp, Belgium. Sales price is €232 million, which is about U.S. $316 million. Sonic said the acquisition is conditional upon a small number of closing conditions and is expected to close within two weeks.
Medhold NV is Belgium’s second largest laboratory company. It was created in November 2007 by a merger of AML-Raitol and Medish Labo D Van Waes. Waterland Private Equity became a 50% owner at that time. The clinical laboratory company provides clinical laboratory testing and veterinary testing services.